Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 112 of 6351
-
Can breathing pure oxygen boost stroke recovery?
Disease control CompletedThe purpose of this study is to determine the efficacy and safety of Normobaric Hyperoxia combined with intravenous thrombolysis for acute ischemic stroke.
Phase 3 • Sponsor: Ji Xunming,MD,PhD • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Zapping lung nerves could ease heart Failure-Related high blood pressure
Disease control OngoingIt's a phase III, prospective, multicenter, randomized controlled trial to evaluate the safety and efficacy of the pulmonary artery denervation (PADN) for heart failure (HF) patients diagnosed with pulmonary hypertension associate with left heart disease (PH-LHD) by right heart c…
Phase 3 • Sponsor: Pulnovo Medical (Wuxi) Co., Ltd. • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Can scheduled malaria drugs shield infants from severe illness?
Prevention CompletedThe Plus Project will assess the impact, operational feasibility, efficacy, effectiveness, and cost-effectiveness of PMC. Specifically, the impact evaluation will involve monitoring a passive cohort of all children in the study area reporting all doses of SP received and the numb…
Sponsor: London School of Hygiene and Tropical Medicine • Aim: Prevention
Last updated Sep 09, 2026 15:00 UTC
-
New breast cancer pill combo shows promise in Late-Stage trial
Disease control OngoingThe purpose of this study is to understand the safety and effects of the study medicine vepdegestrant (ARV-471/PF-07850327) given together with palbociclib in advanced breast cancer. In particular, the study will compare the combination of vepdegestrant plus palbociclib to standa…
Phase 3 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
One-Time gene therapy could free PKU patients from strict diet
Disease control OngoingThis is a single group Phase 1/Phase 2, 1-arm, open-label study with SAR444836, an adeno-associated virus (AAV) vector-mediated gene transfer of human phenylalanine hydroxylase (PAH), for the treatment of adult participants with phenylketonuria (PKU) on a chronic, stable diet. Th…
Phase 1/2 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New short-course malaria cure could save thousands
Cure CompletedThe proportion of malaria that is the Plasmodium vivax species is increasing in Indonesia. Reducing vivax malaria will require innovative solutions to cure both the blood and liver stages of the disease. This study will evaluate of the feasibility of implementing point-of-care gl…
Sponsor: Menzies School of Health Research • Aim: Cure
Last updated Jun 27, 2026 08:11 UTC
-
Engineered immune cells take on tough lymphoma
Disease control Recruiting nowThis is a multi-center, phase I/II study to determine the safety and efficacy of TC011(CD19 Targeted CAR-T) in adult patients with relapsed or refractory large B-cell non -hodgkin lymphoma.
Phase 1/2 • Sponsor: TICAROS Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Could a second Clot-Buster boost stroke recovery?
Disease control CompletedA multicenter, prospective, open-label, blinded endpoint, randomized controlled trial aiming at evaluating the efficacy and safety of intra-arterial recombinant human tissue plasminogen activator (rt-PA) after successful recanalization of acute large vessel occlusion in the anter…
Phase 3 • Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Could a single drug replace chemo for some colon cancers?
Disease control Recruiting nowThe primary purpose of this study is to evaluate the efficacy of perioperative dostarlimab compared with standard of care (SOC) in participants with untreated T4N0 or Stage III (resectable), defective mismatch repair/ microsatellite instability high (dMMR/MSI-H) colon cancer.
Phase 3 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Once-Daily pill shows promise for obesity in japanese patients
Disease control CompletedThe main purpose of this study is to investigate the efficacy and safety of oral orforglipron in participants with obesity disease with obesity-related health problems.
Phase 3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
New combo therapy takes on tough lymphoma
Disease control Recruiting nowThis phase II trial tests how well zanubrutinib and lisocabtagene maraleucel (liso-cel) work together in treating patients with Richter's syndrome that has come back (recurrent) or does not respond to treatment (refractory). Richter's syndrome occurs when chronic lymphocytic leuk…
Phase 2 • Sponsor: Aseel Alsouqi • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Light and magnets: a new weapon against Alzheimer's?
Disease control Recruiting nowThis is a controlled investigation, with randomization of the patients, which aims at demonstrating the efficacy of device RGn600 in treating patients with mild-to-moderate Alzheimer's disease (AD). RGn600 is a non-invasive medical device which is applied on the head (helmet) and…
Sponsor: REGEnLIFE SAS • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Double-Barreled CAR t takes on Hard-to-Treat myeloma
Disease control Recruiting nowThis trial is a Phase 1b/2, open-label, multicenter study of AZD0120, a CD19/BCMA dual CAR T-cell therapy, in adult subjects with relapsed/refractory multiple myeloma.
Phase 1/2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Can a simple preventive drug cut malaria and anemia in infants?
Prevention CompletedThe Plus Project will assess the impact, operational feasibility, efficacy, effectiveness, and cost-effectiveness of PMC. Specifically, the impact evaluation will involve monitoring a passive cohort of all children in the study area reporting all doses of SP received and the numb…
Sponsor: London School of Hygiene and Tropical Medicine • Aim: Prevention
Last updated Sep 09, 2026 15:00 UTC
-
Personalized mRNA vaccine shows promise in stopping melanoma return
Disease control OngoingThe purpose of this study is to learn if intismeran autogene which is an individualized neoantigen therapy (INT; formerly, called messenger ribonucleic acid \[mRNA\]-4157) with pembrolizumab (MK-3475) is safe and prevents cancer from returning in people with high-risk melanoma. R…
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Engineered immune cells take on lupus and scleroderma
Disease control Recruiting nowThe investigational product is designed to effectively combat B cells in patients with autoimmune diseases. Autologous T cells enriched with CD4/CD8 are genetically engineered using a lentiviral vector to express chimeric antigen receptors (CARs) that target the CD19 antigen on t…
Phase 1/2 • Sponsor: Miltenyi Biomedicine GmbH • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Can a new drug combo outperform standard care for a common type of heart failure?
Disease control Recruiting nowHeart failure with moderately reduced ejection fraction (HFmrEF) is a frequent disease associated with significant morbidity and mortality and therefore requires effective therapies that may improve clinical outcomes. The most common reason of HFmrEF is ischemic injury, usually c…
Phase 3 • Sponsor: John Paul II Hospital, Krakow • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Hope for rare brain disease: new drug trial aims to stall deadly decline
Disease control OngoingA Clinical Study to Assess the Efficacy and Safety of Leriglitazone in Adults Male Subjects with Cerebral Adrenoleukodystrophy.
Phase 3 • Sponsor: Minoryx Therapeutics, S.L. • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
New weekly shot shows promise for obesity, knee pain, and sleep apnea
Disease control CompletedThe purpose of this study is to evaluate the efficacy and safety of retatrutide in participants who have obesity or overweight (J1I-MC-GZBJ master protocol) including subsets of participants who have knee osteoarthritis (OA) (J1I-MC-GOA1) or who have obstructive sleep apnea (OSA)…
Phase 3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
New oral vaccine aims to shield infants from severe rotavirus
Vaccine CompletedThis is a randomized, double-blind, phase 3 study to evaluate the Efficacy, Safety, and Immunogenicity of ROTAVAC 5D, a live attenuated rotavirus vaccine in healthy infants. A total of 5800 healthy Chilean infants will be recruited in this study and randomized to receive either …
Phase 3 • Sponsor: University of Chile • Aim: Vaccine
Last updated Jul 02, 2026 00:00 UTC